GSA Capital Partners LLP purchased a new stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 4,929 shares of the company's stock, valued at approximately $1,171,000.
A number of other large investors have also recently bought and sold shares of CAH. Integrated Wealth Concepts LLC boosted its holdings in shares of Cardinal Health by 6.9% during the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company's stock valued at $601,000 after acquiring an additional 280 shares during the period. Jones Financial Companies Lllp increased its position in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after acquiring an additional 14,034 shares during the period. Arrowstreet Capital Limited Partnership acquired a new position in shares of Cardinal Health during the second quarter valued at $1,935,000. Cerity Partners LLC raised its position in shares of Cardinal Health by 17.0% during the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company's stock worth $6,792,000 after buying an additional 5,880 shares in the last quarter. Finally, Nebula Research & Development LLC lifted its position in Cardinal Health by 34.4% in the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company's stock worth $1,736,000 after purchasing an additional 2,646 shares during the period. Institutional investors own 87.17% of the company's stock.
Cardinal Health Stock Performance
Shares of CAH stock opened at $235.68 on Tuesday. The stock's 50 day simple moving average is $230.93 and its 200 day simple moving average is $217.34. Cardinal Health, Inc. has a twelve month low of $145.87 and a twelve month high of $258.30. The company has a market capitalization of $54.81 billion, a price-to-earnings ratio of 32.60, a PEG ratio of 1.26 and a beta of 0.49.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The firm had revenue of $63.67 billion during the quarter, compared to analysts' expectations of $65.15 billion. During the same quarter in the prior year, the business earned $2.08 earnings per share. The company's revenue was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 12.55 EPS for the current fiscal year.
Cardinal Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Thursday, October 1st. Cardinal Health's dividend payout ratio is 28.49%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on CAH shares. Wall Street Zen raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, July 4th. Weiss Ratings upgraded Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a report on Wednesday, August 5th. UBS Group upped their price objective on shares of Cardinal Health from $274.00 to $280.00 and gave the company a "buy" rating in a research note on Wednesday, August 12th. JPMorgan Chase & Co. raised their price target on Cardinal Health from $215.00 to $260.00 and gave the stock a "neutral" rating in a research note on Thursday, August 13th. Finally, Leerink Partners set a $292.00 price target on Cardinal Health in a research note on Tuesday, August 11th. Fifteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $265.93.
Get Our Latest Stock Report on CAH
Cardinal Health Company Profile
(
Free Report)
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Stories
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
